Tests generally appear in the order most useful for common clinical situations
| Test name: Beta-hCG, Urine Qualitative |
| ARUP #: 0020229 |
| Methodology: Immunoassay |
| Use: Exclude pregnancy |
| Test name: Beta-hCG, Serum Qualitative |
| ARUP #: 0020063 |
| Methodology: Immunoassay |
| Use: Exclude pregnancy |
| Test name: Thyroid Stimulating Hormone |
| ARUP #: 0070145 |
| Methodology: Quantitative Electrochemiluminescent Immunoassay |
| Use: Rule out thyroid disease as etiology of amenorrhea |
| Test name: Prolactin |
| ARUP #: 0070115 |
| Methodology: Quantitative Chemiluminescent Immunoassay |
| Use: Identify prolactinemia as etiology of amenorrhea |
| Test name: Luteinizing Hormone and Follicle Stimulating Hormone |
| ARUP #: 0070193 |
| Methodology: Quantitative Electrochemiluminescent Immunoassay |
| Use: Diagnose amenorrhea |
| Test name: Testosterone, Free & Total (Includes Sex Hormone Binding Globulin), Females or Children |
| ARUP #: 0081056 |
Methodology: Quantitative High Performance Liquid Chromatography-Tandem Mass Spectrometry/Electrochemiluminescent Immunoassay The concentration of free testosterone is derived from a mathematical expression based on the constant for the binding of testosterone to sex hormone binding globulin. |
| Use: Aid in evaluation of secondary amenorrhea |
| Test name: Dehydroepiandrosterone Sulfate, Serum |
| ARUP #: 0070040 |
| Methodology: Quantitative Electrochemiluminescent Immunoassay |
| Use: Aid in evaluation of secondary amenorrhea |
| Test name: Estradiol, Adult Premenopausal Female, Serum or Plasma |
| ARUP #: 0070045 |
| Methodology: Quantitative Chemiluminescent Immunoassay |
| Use: Aid in evaluation of secondary amenorrhea |
Additional Tests Available
| Test name: Estrogens, Fractionated by Tandem Mass Spectrometry |
| ARUP #: 0093248 |
| Methodology: Quantitative High Performance Liquid Chromatography-Tandem Mass Spectrometry |
| Comments: Diagnose amenorrhea Components include estradiol, estrone and calculated total estrogens value |
| Test name: Virilization Panel 1 |
| ARUP #: 2002028 |
| Methodology: Quantitative High Performance Liquid Chromatography-Tandem Mass Spectrometry |
| Comments: |
| Test name: Virilization Panel 2 |
| ARUP #: 2002281 |
| Methodology: Quantitative High Performance Liquid Chromatography-Tandem Mass Spectrometry |
| Comments: |
| Test name: Follicle Stimulating Hormone, Serum |
| ARUP #: 0070055 |
| Methodology: Quantitative Electrochemiluminescent Immunoassay |
| Comments: |
| Test name: Luteinizing Hormone, Pooled |
| ARUP #: 0020780 |
| Methodology: Quantitative Electrochemiluminescent Immunoassay |
| Comments: |
| Test name: Testosterone, Bioavailable & Sex Hormone Binding Globulin (Includes Total Testosterone), Females or Children |
| ARUP #: 0081057 |
Methodology: Quantitative High Performance Liquid Chromatography-Tandem Mass Spectrometry/Electrochemiluminescent Immunoassay The concentrations of free and bioavailable testosterone are derived from mathematical expressions based on constants for the binding of testosterone to albumin and/or sex hormone binding globulin. |
| Comments: |
| Test name: Testosterone Free, Females or Children |
| ARUP #: 0081059 |
Methodology: Quantitative High Performance Liquid Chromatography-Tandem Mass Spectrometry/Electrochemiluminescent Immunoassay The concentration of free testosterone is derived from a mathematical expression based on the constant for the binding of testosterone to sex hormone binding globulin. |
| Comments: Recommended for women and children due to improved accuracy of testosterone by LC-MS/MS |
| Test name: Testosterone, Females or Children |
| ARUP #: 0081058 |
| Methodology: Quantitative High Performance Liquid Chromatography-Tandem Mass Spectrometry |
| Comments: |
| Test name: Testosterone, Urine |
| ARUP #: 2004772 |
| Methodology: Quantitative Gas Chromatography Mass Spectrometry |
| Comments: |
| Test name: Estradiol, Males, Children or Postmenopausal Females, by Tandem Mass Spectrometry |
| ARUP #: 0093247 |
| Methodology: Quantitative High Performance Liquid Chromatography-Tandem Mass Spectrometry |
| Comments: |
| Test name: Fragile X (FMR1) Screen with Reflex to Fragile X (FMR1) Diagnostic |
| ARUP #: 2001946 |
| Methodology: Polymerase Chain Reaction/Fragment Analysis |
| Comments: If screen suggests a pre- or full mutation, Fragile X Diagnostic will be added for analysis of sizing and methylation |
| Test name: Fragile X (FMR1) Diagnostic |
| ARUP #: 0040011 |
| Methodology: Southern Blot/Polymerase Chain Reaction/Fragment Analysis |
| Comments: |
| Test name: Chromosome Analysis, Rule Out Mosaicism |
| ARUP #: 2002287 |
| Methodology: Giemsa-Band Analysis |
| Comments: |
| Test name: Estrone, by Tandem Mass Spectrometry |
| ARUP #: 0093249 |
| Methodology: Quantitative High Performance Liquid Chromatography-Tandem Mass Spectrometry |
| Comments: |
| Test name: Beta-hCG, Serum Quantitative |
| ARUP #: 0070025 |
| Methodology: Chemiluminescent Immunoassay |
| Comments: |
| Test name: Androstenedione |
| ARUP #: 2001638 |
| Methodology: Quantitative High Performance Liquid Chromatography-Tandem Mass Spectrometry |
| Comments: |
| Test name: Dehydroepiandrosterone, Serum or Plasma |
| ARUP #: 2001640 |
| Methodology: Quantitative High Performance Liquid Chromatography-Tandem Mass Spectrometry |
| Comments: |